RYET:NASDAQRuanyun Edai Technology Inc. Analysis
Data as of 2026-07-20 - not real-time
$1.03
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Ruanyun Edai Technology is trading in a narrow range with the 20‑day SMA just above the 50‑day SMA, suggesting a muted bullish bias, while the 200‑day SMA remains higher, keeping long‑term pressure on the price. The RSI hovers near the midpoint, indicating no clear overbought or oversold condition, but the MACD histogram is negative and the signal line is bearish, pointing to short‑term downside momentum. Volume has been rising, yet the stock sits close to its identified support level, and the 30‑day volatility is exceptionally high, reflecting a very erratic price pattern. Fundamentally, the company reports steep revenue contraction, negative margins across the board, and sizable cash‑burn, while its balance sheet shows a debt‑to‑equity ratio that is elevated for a micro‑cap. The valuation multiples—price‑to‑book and price‑to‑sales—are well above typical benchmarks for a loss‑making firm, reinforcing the impression of an overvalued price.
Given the combination of weak earnings, aggressive debt load, high beta, and a sector that faces regulatory scrutiny in China, the risk profile is skewed toward the downside. The lack of any dividend further limits income‑oriented appeal, and the limited analyst coverage leaves investors without a clear consensus. Overall, the stock appears more suited for risk‑averse investors to avoid, unless a material operational turnaround emerges.
Given the combination of weak earnings, aggressive debt load, high beta, and a sector that faces regulatory scrutiny in China, the risk profile is skewed toward the downside. The lack of any dividend further limits income‑oriented appeal, and the limited analyst coverage leaves investors without a clear consensus. Overall, the stock appears more suited for risk‑averse investors to avoid, unless a material operational turnaround emerges.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- bearish MACD and proximity to support
- escalating short‑term volatility
- negative operating cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential for regulatory relief in the education sector
- need for significant cost restructuring
- valuation still detached from fundamentals
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- persistent revenue decline and loss making
- high debt burden relative to equity
- exposure to Chinese policy shifts
Key Metrics & Analysis
Financial Health
Revenue Growth-91.10%
Profit Margin-147.57%
ROE-138.15%
ROA-21.26%
Debt/Equity60.75
P/B Ratio4.7
Op. Cash Flow$-7242444
Free Cash Flow$-6088976
Technical Analysis
TrendNeutral
RSI49.3
Support$0.95
Resistance$1.18
MA 20$1.05
MA 50$1.01
MA 200$1.09
MACDBearish
VolumeIncreasing
Fear & Greed Index88.34
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.57
Volatility115.55%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.